Serial Number | 86481014 |
Word Mark | VIBERZI |
Filing Date | Monday, December 15, 2014 |
Status | 702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED |
Status Date | Tuesday, July 19, 2022 |
Registration Number | 4928665 |
Registration Date | Tuesday, March 29, 2016 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, June 9, 2015 |
Amendment to a Registration/Renewal Certificate | In the statement, Page 1, line 5, through line 36, and Page 2, line 1, through line 9 is deleted, and Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome is inserted. |
Goods and Services | [ Oral, Transdermal, Injectable and Intravaginal Contraceptives; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the sensory organs; Pharmaceuticals and medicines for the central nervous system; Pharmaceuticals and medicines for the urogenital organs; Pharmaceuticals and medicines for the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; ] Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome [ ; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics, Antifungals, Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Excluding pharmaceuticals for the diagnosis and/or treatment of diabetes ] |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, December 19, 2014 |
Primary Code | 005 |
First Use Anywhere Date | Monday, December 14, 2015 |
First Use In Commerce Date | Monday, December 14, 2015 |
Party Name | ALLERGAN HOLDINGS UNLIMITED COMPANY |
Party Type | 31 - New Owner After Registration |
Legal Entity Type | 99 - Other |
Address | DUBLIN 17 IE |
Party Name | FURIEX PHARMACEUTICALS, LLC |
Party Type | 30 - Original Registrant |
Legal Entity Type | 16 - Limited Liability Company |
Address | PARSIPPANY, NJ 07054 |
Party Name | FURIEX PHARMACEUTICALS, LLC |
Party Type | 21 - New Owner After Publication |
Legal Entity Type | 16 - Limited Liability Company |
Address | PARSIPPANY, NJ 07054 |
Party Name | Furiex Pharmaceuticals, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Parsippany, NJ 07054 |
Party Name | Furiex Pharmaceuticals, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Parsippany, NJ 07054 |
Event Date | Event Description |
Tuesday, July 19, 2022 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
Tuesday, July 19, 2022 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
Tuesday, July 19, 2022 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
Wednesday, February 9, 2022 | TEAS SECTION 8 & 15 RECEIVED |
Monday, March 29, 2021 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
Thursday, January 7, 2021 | AMENDMENT UNDER SECTION 7 ¿ PROCESSED |
Tuesday, January 5, 2021 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
Tuesday, October 6, 2020 | TEAS SECTION 7 REQUEST RECEIVED |
Tuesday, October 6, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Tuesday, October 6, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Tuesday, October 6, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Tuesday, October 6, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Tuesday, October 6, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Wednesday, August 10, 2016 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Tuesday, March 29, 2016 | REGISTERED-PRINCIPAL REGISTER |
Thursday, February 25, 2016 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
Wednesday, February 24, 2016 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
Saturday, February 6, 2016 | STATEMENT OF USE PROCESSING COMPLETE |
Tuesday, December 15, 2015 | USE AMENDMENT FILED |
Thursday, January 28, 2016 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Tuesday, December 15, 2015 | TEAS STATEMENT OF USE RECEIVED |
Tuesday, December 15, 2015 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Wednesday, November 4, 2015 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
Tuesday, August 4, 2015 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, June 9, 2015 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, June 9, 2015 | PUBLISHED FOR OPPOSITION |
Wednesday, May 20, 2015 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Wednesday, May 6, 2015 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Wednesday, May 6, 2015 | ASSIGNED TO LIE |
Tuesday, April 14, 2015 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, April 8, 2015 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, April 8, 2015 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, April 8, 2015 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, March 27, 2015 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, March 27, 2015 | NON-FINAL ACTION E-MAILED |
Friday, March 27, 2015 | NON-FINAL ACTION WRITTEN |
Wednesday, March 25, 2015 | ASSIGNED TO EXAMINER |
Friday, December 19, 2014 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Thursday, December 18, 2014 | NEW APPLICATION ENTERED IN TRAM |